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A bumpy road to the diagnosis 
of metastatic lung cancer
ABSTRACT:
Cardiac tumors pose the uncommon group of disorders and most of them are metastases. They are 
generally localized in the left heart and may present with non-specific symptoms. Diagnosis may be often 
difficult due to the presence other heart diseases. The gold standard in diagnosing is non-invasive imaging.
We present a case of a 77-year-old male admitted to our hospital due to flu symptoms, headaches and loss 
of weight in the last 2–3 weeks. The diagnostic process including computed tomography (CT) and magnetic 
resonance imaging revealed pathological contrast enhancement in the left parietal lobe, whereas subsequent 
transthoracic echocardiography disclosed a pathological oval mass 2.5 x 3.5 cm in the left heart suspected 
of a metastasis. Results of echocardiography turned the diagnostic process around and extended to bron-
choscopy and abdominal CT. Finally, central left lung tumor with metastases to lungs, pleura, lymphoid nodes 
of the right hilar, left ventricle, left suprarenal gland and central nervous system was diagnosed.
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Transthoracic echocardiography (TTE) is widely 
known as a non-invasive method to characterize the 
structure of the heart, its dimensions, blood circulation 
and other physical aspects. It may also describe cardiac 
hypertrophy, which is classified as concentric or eccen-
tric change based on relative heart wall thickness. Car-
diac hypertrophy may have a different background, e.g. 
hypertension, valve stenosis, endocrine disorders or 
genetic aspects. Also, cardiac tumors are rare disorders 
which result in heart wall hypertrophy. It is less likely 
to find the primary tumor, because most of them are 
metastases. The incidence of metastases to the heart 
is underestimated and may be up to 25% according to 
some post-mortem studies [1]. Lung cancer, that has 
the highest prevalence in cardiac metastases, is the 
most commonly diagnosed cancer in the world and 
associated with the largest number of cancer-related 
deaths [2, 3]. Computed tomography (CT) is a basic 
diagnostic modality of lung cancer, and the timely di-
agnosis of cardiac metastases may improve prognosis 
by faster diagnosis of the primary tumor and help to 
prevent acute complications like cardiac tamponade 
or pulmonary edema.
We present a case of a male in whom the TTE gave 
an opportunity to make a diagnosis and vitally change 
the treatment.
Case presentation
We present a case of a 77-year-old male with 
a history of hypertension, hyperthyroidism (treated 
with radioiodine therapy) and with right mediastinum 
enlargement, which was under observation since 
2001 (most likely goitre). In 2011 the patient was offered 
surgical removal of suspected tumor but did not agree 
to proceed. The patient was admitted to our hospital 
due to fever present in the last 2-3 weeks (up to 39OC), 
dry cough, lack of appetite, increasing tiredness and 
weight loss. Before admission, the patient was treated 
with oral antibiotics (amoxicillin + clavulanic acid fol-
lowed by ciprofloxacin) with no improvement and with 
persistent fever. At admission, the patient was stable, 
with no fever. During physical examination, no abnor-
malities were found except for paleness.  The abnormal 
laboratory test findings included: WBC — 13.11x109/L, 
serum fasting glucose — 168mg/dL, C-reactive protein 
— 154.1mg/L, and serum creatinine — 1.60mg/dL. 
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Figure 2. Transthoracic echocardiography showing the 
infiltration of the intraventricular septum, the oval mass, 
and the effusion in the pericardium
Figure 1. A.  Magnetic resonance imaging showing the metastatic lesion in the left parietal lobe; B. Computed tomography 
showing the large primary tumor in the right lung
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Ambulatory chest radiogram apart from the lesion in the 
right mediastinum did not reveal any abnormalities. In 
chest radiogram at admission, additional opacities in 
the right hilar were noted and described as suspected 
of being segmental atelectasis due to compression, as 
well as atelectasis in the left costodiaphragmatic recess, 
were mentioned. Ultrasonography of the abdomen was 
normal. Blood cultures were twice negative. The patient 
was treated with ceftriaxone. No fever was observed, 
cough decreased, the decision about discharge was 
made. At the day of the discharge, a patient’s family 
mentioned severe headaches the patient was suffering 
from for several weeks before admission. According to 
them headaches required large doses of nonsteroidal 
anti-inflammatory drugs the patient was taking on his 
own, also during current hospitalization (the probable 
reason for the lack of fever). Neurologist consulting 
the patient recommended head MRI, which was made 
and revealed at least 7 areas of pathological contrast 
enhancement, largest measuring 12 mm localized in 
left parietal lobe and no other meaningful abnormalities 
(Fig. 1A). Taking all under consideration diagnosis of 
multiple abscesses was made. As a part of the further 
diagnostic process in order to find abscesses origin 
TTE was performed. It revealed slight left atrium en-
largement, cardiac effusion with a maximum thickness 
of 12 mm, hypertrophy of the posterior and lateral left 
ventricular (LV) wall with an oval mass – 3.5 x 2.5cm. 
Cardiomyopathy to be differentiated with inflammatory 
infiltration and the cardiac tumor was suggested (Fig. 2). 
Above-mentioned LV wall showed contractility ab-
normalities, but no signs of valve disease or infective 
endocarditis were found. At that point, taking under 
consideration that the most common tumors of the heart 
are metastases, a neoplastic process with multiple me-
tastases started to be suspected. Chest and abdominal 
CT and bronchoscopy were performed. Bronchoscopy 
revealed in the area of carina of trachea a pathological 
vascular network, and a concentric edema of the initial 
segments of the left secondary bronchi with stenosis 
of the left inferior lobar bronchus origin. Chest and 
abdominal CT showed a pathological mass with signs 
of necrosis and maximum size of 6 cm in the right hilar 
(Fig. 1B), with amputation of one of the right pulmo-
nary artery branches, with right inferior lobar bronchus 
blockage, and with enlarged lymph nodes in the right 
hilar. A mass was interfusing with a right main bronchus 
wall and segmentally with a descending aortic wall. At-
electasis secondary to bronchi compression in the right 
inferior pulmonary lobe were also noted. Several lesions 
suspected of metastases in the right lung were also 
present. Lesions suspected of metastases were also 
present in the LV wall – localizing from a basal anterior 
segment, through antero- and inferolateral segments, 
infiltrating epicardium, with pericardial effusion. Also, 
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similar lesions were present in the intraventricular wall. 
Additionally, metastases in the left suprarenal gland 
and pulmonary pleura were present. The lesion in the 
upper right mediastinum was described as polycystic, 
with a size of 8.5 cm – most likely to be a goiter. The 
central left lung tumor with metastases to lungs, pleura, 
lymph nodes of the right hilar, left suprarenal gland, LV 
and intraventricular wall were diagnosed. Taking all into 
account, lesions in the central nervous system were also 
diagnosed as metastases, and the patient was referred 
for further treatment to the oncology department.
Discussion
Heart muscle hypertrophy may have different 
etiologies: physiological in the athlete’s heart, or rather 
pathological, i.e. in hypertension, valvular heart disease 
(stenosis), hypertrophic cardiomyopathy or a neoplas-
tic process.
Transthoracic echocardiography is one of the main 
imaging modalities used in differentiating the cause of 
hypertrophy.  In our case hypertrophy of the posterior 
and lateral LV walls with an oval mass was diagnosed. 
It suggested cardiomyopathy to be differentiated with 
inflammatory infiltration and cardiac tumor. Although 
taking into account full clinical picture metastatic lesions 
seemed the most probable and the patient was further 
diagnosed in that direction. 
Cardiac tumors belong to a group of rare clinical dis-
orders with a frequency, depending on the population 
study taken into account, differing between 0.0017% 
and 0.33%. Only 5% are classified as primary tumors 
[4]. Most of them are metastases. However, their clin-
icopathological state has not been explicated yet [5]. 
Nevertheless, few potential primary types can be distin-
guished: myxomas (being the most popular – 72.6%), 
followed by fibromas (6.9%) and sarcomas (6.4%) [6]. 
Cardiac metastases are most common in patients 
in the sixth and seventh decade of life, without sex 
preferences. Generally, every malignant tumor can 
metastasize to the heart, but the most common are 
carcinomas of the lung, breast, esophagus, lymphoma, 
leukemia and melanoma [7]. Lung cancers make up 
over 38% of all metastases to the heart (adenocarcino-
ma – 14.6%; poorly differentiated – 12.4%; squamous 
cell – 11.8%) [3]. However, clinical picture and cardiac 
symptoms depend mainly on the size and localization 
of the tumor than its histological type [1, 7].
The diagnosis is extremely difficult due to its 
non-specific symptoms, that can be wrongly attributed 
to other cardiac diseases. Moreover, cardiac metasta-
ses remain often asymptomatic for a long time, there-
fore heart involvement is often not noticeable till death 
[7]. While symptoms are present, they may manifest 
as heart rhythm disturbances, conduction disorders, 
angina pectoris, dyspnea or cough [1]. Metastases to 
pericardium are preferable from lung and breast can-
cers, and they may lead to a pericardial effusion [7].  It 
is one of the most feared complications since may lead 
to death. It can be mild and give slightly symptoms like 
in our case; however, it may also increase rapidly and 
require pericardiocentesis [3].
Heart metastases are often not only the the first, 
but also the only change that indicates the presence 
of a malignant tumor [3]. At the time of diagnosis, 
metastases are often not limited to the heart [8]. The 
situation was similar in our case, at the moment of the 
diagnosis, the patient had not only metastases to the 
heart but also to other organs, i.e. the suprarenal gland 
and the right lung. In addition, the tumor infiltrated vital 
organs — descending aorta and left main bronchus.
There are no guidelines for the treatment of cardiac 
metastases, mainly due to low incidence and lack of 
evidence [8, 9]. Treatment is generally focused on the 
underlying tumor [10]. Treatment of lung cancer may 
be divided into surgical and non-surgical i.e. chemo-
therapy, radiotherapy, immunotherapy. The choice of 
method of the treatment depends on the histological 
diagnosis and stage and the methods may be combined 
to increase effectiveness [11]. Cardiac treatment is 
mainly limited to palliative measures [7]. Surgery may 
be considered in symptomatic patients to alleviate the 
symptoms and/or in selected cases to remove the tu-
mor [8]. Resection may be performed among patients 
without metastases in other organs when the tumor 
can be removed completely [9]. Among inoperable and 
asymptomatic patients, nonsurgical treatment should 
be initiated [8]. Since chemotherapy and tumor resec-
tion may alleviate symptoms and prolong survival, our 
patient was referred to the oncology department [6].
Conclusions
Cardiac metastases are rare disorders and occur 
mostly in older patients. They may be the first and the 
only disorder indicating an active tumor process. Pre-
dominantly, metastases to the heart origin from lung 
cancer. In our case, taking all into account, the primary 
left lung tumor with metastases, including those in the 
heart wall was diagnosed. Our case suggests that de-
spite unspecific symptoms, one of the simplest imaging 
modalities like TTE may still turn the diagnostic process 
around and help to give an accurate diagnosis. 
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